Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid

US11111263B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11111263-B2
Application numberUS-202016876878-A
CountryUS
Kind codeB2
Filing dateMay 18, 2020
Priority dateMay 20, 2019
Publication dateSep 7, 2021
Grant dateSep 7, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a process for manufacturing (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid with the formula (Id) below and salts thereofThe compound of formula (Id) is a prodrug of a catecholamine for use in treatment of neurodegenerative diseases and disorders such as Parkinson's Disease.The invention also relates to new intermediates of said process.

First claim

Opening claim text (preview).

The invention claimed is: 1. A process for the preparation of compound (Id) with the formula below from compound (I) with the formula below comprising the following step reacting compound (I), or a salt thereof, with benzyl halogenide to obtain compound (A2) according to the reaction scheme below wherein Ph is phenyl and X is selected from the group consisting of Cl, Br and I. 2. The process according to claim 1 , wherein: a) said benzyl halogenide is benzyl chloride and X is Cl; or b) said benzyl halogenide is benzyl bromide and X is Br. 3. A compound of formula (A2) below: or a salt thereof. 4. The process according to claim 1 for the preparation of compound (Id) with the formula below from compound (I) with the formula below comprising the following step subjecting compound (A2) to a debenzylation reaction to obtain compound (A3), or a salt thereof according to the reaction scheme below 5. A compound of formula (A3) below: or a salt thereof. 6. The process according to claim 4 , wherein the debenzylation reaction comprises the steps of: I) reacting trimethylsilyl iodide with compound (A2) to form a mixture; and II) adding an alcohol to said mixture from step I) to obtain compound (A3) or a salt thereof; and III) optionally isolating compound (A3), or a salt thereof as obtained in step (II). 7. The process according to claim 6 , wherein the alcohol added to said mixture in step II) is selected from the group consisting of MeOH, n-heptyl alcohol, and ethanol. 8. The process according to claim 4 , wherein compound (A3) is obtained in the form of a hydroiodide salt with the formula (A3-HI) below 9. The compound according to claim 5 , which is in the form of a hydroiodide salt with the formula (A3-HI) below 10. The process according to claim 1 for the preparation of compound (Id) with the formula below from compound (I) with the formula below comprising the following step reacting compound (A3), or salt thereof, with (2S,3S,4S,5R,6R)-2-(methoxycarbonyl)-6-(2,2,2-trichloro-1-iminoethoxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate to obtain compound (A4) according to the reaction scheme below 11. The process according to claim 10 , wherein compound (A3) is in the form of the hydroiodide salt (A3-HI) with the formula below: 12. A compound of formula (A4) below: or a salt thereof. 13. A process for the preparation of compound (Id) with the formula below from compound (I) with the formula below comprising the following step reacting compound (A4) with alkali-hydroxide to obtain (A5-Y) according to the reaction scheme below wherein Y is selected from Li, Na and K. 14. The process according to claim 13 , wherein: a) said alkali hydroxide is lithium hydroxide and Y is Li; or b) said alkali hydroxide is sodium hydroxide and Y is Na; or c) said alkali hydroxide is potassium hydroxide and Y is K. 15. A compound of formula (A5) below: or a salt thereof. 16. The compound according to claim 15 which is in the form of an alkali salt depicted below wherein Y is selected from the group consisting of Li, Na and K. 17. The process according to claim 1 for the preparation of compound (Id) with the formula below from compound (I) with the formula below comprising the following step debenzylating compound (A5-Y) to obtain compound (Id) according to the reaction scheme below wherein Y is selected from the group consisting of Li, Na, and K. 18. The process according to claim 1 for the preparation of compound (Id) from compound (I) comprising a step reacting compound (I), or a salt thereof, with benzyl halogenide to obtain compound (A2) according to the reaction scheme below wherein Ph is phenyl and X is selected from the group consisting of Cl, Br and I; followed by a step subjecting compound (A2) to a debenzylation reaction to obtain compound (A3), or a salt thereof according to the reaction scheme below followed by a step reacting compound (A3), or salt thereof, with (2S,3S,4S,5R,6R)-2-(methoxycarbonyl)-6-(2,2,2-trichloro-1-iminoethoxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate to obtain compound (A4) according to the reaction scheme below followed by a step reacting compound (A4) with alkali-hydroxide to obtain (A5-Y) according to the reaction scheme below wherein Y is selected from Li, Na and K; followed by a step debenzylating compound (A5-Y) to obtain compound (Id) according to the reaction scheme below wherein Y is selected from the group consisting of Li, Na and K.

Assignees

Inventors

Classifications

  • Optical isomers · CPC title

  • Processes for the preparation of sugar derivatives · CPC title

  • C07H17/02Primary

    Heterocyclic radicals containing only nitrogen as ring hetero atoms · CPC title

  • C07D221/08Primary

    Aza-anthracenes · CPC title

  • Ring systems of three rings · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11111263B2 cover?
The present invention relates to a process for manufacturing (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid with the formula (Id) below and salts thereofThe compound of formula (Id) is a prodrug of a catecholamine for use in treatment of neurodegenerative diseases and disorders such…
Who is the assignee on this patent?
H Lundbeck As
What technology area does this patent fall under?
Primary CPC classification C07H17/02. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 5 related publications on this page (citations in our corpus or others sharing the same primary CPC).